- Home
- ONCY vs FLYX Comparison
ONCY vs FLYX Comparison
Compare ONCY & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- FLYX
- Stock Information
- Founded
- ONCY 1998
- FLYX 2015
- Country
- ONCY Canada
- FLYX United States
- Employees
- ONCY N/A
- FLYX N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- FLYX Blank Checks
- Sector
- ONCY Health Care
- FLYX Finance
- Exchange
- ONCY Nasdaq
- FLYX Nasdaq
- Market Cap
- ONCY 89.7M
- FLYX 79.8M
- IPO Year
- ONCY 1999
- FLYX N/A
- Fundamental
- Price
- ONCY $1.02
- FLYX $3.22
- Analyst Decision
- ONCY Strong Buy
- FLYX
- Analyst Count
- ONCY 5
- FLYX 0
- Target Price
- ONCY $5.00
- FLYX N/A
- AVG Volume (30 Days)
- ONCY 948.7K
- FLYX 25.5K
- Earning Date
- ONCY 11-07-2025
- FLYX 11-13-2025
- Dividend Yield
- ONCY N/A
- FLYX N/A
- EPS Growth
- ONCY N/A
- FLYX N/A
- EPS
- ONCY N/A
- FLYX N/A
- Revenue
- ONCY N/A
- FLYX $347,746,000.00
- Revenue This Year
- ONCY N/A
- FLYX $28.47
- Revenue Next Year
- ONCY N/A
- FLYX $22.44
- P/E Ratio
- ONCY N/A
- FLYX N/A
- Revenue Growth
- ONCY N/A
- FLYX 17.09
- 52 Week Low
- ONCY $0.33
- FLYX $1.90
- 52 Week High
- ONCY $1.51
- FLYX $6.90
- Technical
- Relative Strength Index (RSI)
- ONCY 37.21
- FLYX 37.83
- Support Level
- ONCY $0.92
- FLYX $3.51
- Resistance Level
- ONCY $1.05
- FLYX $4.00
- Average True Range (ATR)
- ONCY 0.08
- FLYX 0.37
- MACD
- ONCY -0.02
- FLYX -0.02
- Stochastic Oscillator
- ONCY 25.00
- FLYX 43.57
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.